研究报告 |
|
|
|
|
一株人源性轮状病毒的分离及适应性培养 |
李松1, 张光明1, 吴晋元1, 尹娜1, 易山1, 米锴1, 曹颖2, 李杨2, 孙茂盛1, 李鸿钧1 |
1. 中国医学科学院/北京协和医学院 医学生物学研究所 云南省重大传染病疫苗工程技术研究中心 云南省重大传染病疫苗研发实验室 昆明 650118; 2. 昆明医科大学 昆明 650031 |
|
Isolation Human Rotavirus Strains and Adaptive Culture |
LI Song1, ZHANG Guang-ming1, WU Jin-yuan1, YIN Na1, YI Shan1, MI Kai1, CAO Ying2, LI Yang2, SUN Mao-sheng1, LI Hong-jun1 |
1. Institute of Medical Biology, Chinese Academy of Medical Science, Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming 650018, China; 2. Kunming Medical University, Kunming 650031, China |
引用本文:
李松, 张光明, 吴晋元, 尹娜, 易山, 米锴, 曹颖, 李杨, 孙茂盛, 李鸿钧. 一株人源性轮状病毒的分离及适应性培养[J]. 中国生物工程杂志, 2013, 33(4): 9-14.
LI Song, ZHANG Guang-ming, WU Jin-yuan, YIN Na, YI Shan, MI Kai, CAO Ying, LI Yang, SUN Mao-sheng, LI Hong-jun. Isolation Human Rotavirus Strains and Adaptive Culture. China Biotechnology, 2013, 33(4): 9-14.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2013/V33/I4/9
|
[1] Parashar U D,Gibson C J,Bresse J S,et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis,2006,12(2):304-306. [2] 梁晓峰,罗凤基,封多佳. 疫苗学.第5版. 北京: 人民卫生出版社,2011. 779-802. Liang X F, Luo F J, Feng D J. Immunology. 5th ed.Beijing: People’s Medical Publishing House, 2011. 779-802. [3] 方肇寅,张丽杰,唐景裕,等. 中国河北省卢龙县婴幼儿轮状病毒腹泻研究. 病毒学报,2005,21( 1): 21-25. Fang G Y,Zhang L J,Tang J Y, et al. Rotavirus diarrhea among children in Lulong County,Hebei Province,China. Chinese Journal of Virology,2005,21(1):21-25. [4] Armah G E,Steele A D,Binka F N, et al. Changing patterns of rotavirus genotypes Ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children. J Clin Mircrobiol,2003,41(6): 2317-2322. [5] 张标,佟琳,易山,等. 轮状病毒规模化纯化方法的建立.中国生物制品学杂志,2012,25(4):480-491. Zhang B,Tong L, Yi S,et al. Development of a method for large-scale purification of rotavirus. Chinese Journal of Biologicals. 2012,25(4):480-491. [6] 国家药典委员会.中华人民共和国药典. 北京:中国医药科技出版社,2010.附录93-94. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing:China Medical Science Press,2010.Appendix 93-94. [7] Greenberg H B, Estes M K. Rotaviruses: from pathogenesis to vaccination. Gastroenterology, 2009, 136(6): 1939-1951. [8] Gorrell R J, Bishop R F. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children. J Med Virol, 1999, 57(2): 204-211. [9] Ward R. Mechanisms of protection against rotavirus infection and disease. Infect Dis J, 2009, 28(Suppl 3): S57-S59. [10] 段招军.人A 组轮状病毒疫苗研究进展.中国新药杂志,2012,21(10):1088-1091. Duan Z J. Progress of human group A rotavirus vaccine. Chinese Journal of New Drugs, 2012,21(10):1088-1091. [11] 赵晓南,李鸿钧,吴晋元,等.秋冬季婴幼儿轮状病毒感染分子流行病学调查.中国公共卫生,2012,28(6):823-825. Zhao X N,Li H J,Wu J Y,et al. Molecular epidemiologic distribution of rotavirus infection in autumn and winter among infants in Zhaotong area of Yunnan province,2010.Chinese Journal of Public Health, 2012,28(6):823-825. [12] 国家药典委员会.中华人民共和国药典. 北京:中国医药科技出版社,2010.15-21. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science Press,2010. 15-21. [13] Centers for Disease Control and Prevention(CDC).Intussusception among recipients of rotavirus vaccine-United Sates 1998-1999.MMWR Morb Mortal Wkly Rep,1999:48(27):577-581. [14] Baylis S A,Finsterbusch T,Bannert N,et al. Analysis of porcine circovirus type 1 detected in Rotarix vaccine. Vaccine,2011,29(4):690-697. [15] 吴浩飞,杨晓明.Vero细胞作为基质的病毒性疫苗研究进展.微生物学免疫学进展,2011,39(3):56-62. Wu H F,Yang X M.Progress of viral vaccine in Vero cells.Progress in Microbiology and Immunology, 2011,39(3):56-62. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|